Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine and Auricular Acupoint Stimulation for Myopia Control in Children
NCT07537166Enrolling by invitation
- Sponsor
- China Medical University Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial of NVK002 in myopia (6 arms), sponsored by China Medical University Hospital. Primary endpoints: Change in corneal curvature (Keratometry), Change in refractive error (Spherical Equivalent) and 7 more. Started Apr 2026; status: enrolling by invitation.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07537166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07537166.